Checkpoint Inhibitor Associated Autoimmune Diabetes and Hashimoto’s Thyroiditis
1.1. Background: Anti-PD-1 antibodies have activity across many cancers. Changes in the balance of the immune system may lead to some autoimmune manifestations, also referred to as immune-related adverse events (IRAEs).
Checkpoint Inhibitor Associated Autoimmune Diabetes and Hashimoto’s Thyroiditis Read More »